MYL5 as a Novel Prognostic Marker is Associated with Immune Infiltrating in Breast Cancer: A Preliminary Study
Background. Myosin light chain plays a vital regulatory function in a large-scale cellular physiological procedure, however, the role of myosin light chain 5 (MYL5) in breast cancer has not been reported. In this study, we aimed to elucidate the effects of MYL5 on clinical prognosis and immune cell...
Saved in:
Main Author: | Minghe Lv (Author) |
---|---|
Format: | Book |
Published: |
Hindawi-Wiley,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictive Models for HCC Prognosis, Recurrence Risk, and Immune Infiltration Based on Two Exosomal Genes: MYL6B and THOC2
by: Zhu J, et al.
Published: (2021) -
CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer
by: Shanping Shi, et al.
Published: (2020) -
Prognostic and immune infiltration features of disulfidptosis-related subtypes in breast cancer
by: Sheng Chen, et al.
Published: (2024) -
AFF3 is a Prognostic Biomarker Correlated with Immune Infiltrates in Triple-Negative Breast Cancer
by: Jing Chen, et al.
Published: (2023) -
CLDN4 as a Novel Diagnostic and Prognostic Biomarker and Its Association with Immune Infiltrates in Ovarian Cancer
by: Pan Hu, et al.
Published: (2023)